文献速递精神分裂症与精神病性障碍会诊联络精神医学

LRRK2介导氟哌啶醇诱导的间接通路纹状体投射神经元改变

LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.
PubMed 文献 · Mol Psychiatry · 2025-04-23

研究探索氟哌啶醇与帕金森病相关亮氨酸富集重复激酶2(LRRK2)在纹状体的信号汇聚。通过药理学或遗传学抑制LRRK2激酶及表达致病突变LRRK2的敲入小鼠模型,行为学显示LRRK2激酶抑制改善氟哌啶醇诱导的小鼠运动改变;电生理与解剖学揭示该抑制干扰氟哌啶醇诱导的间接通路纹状体神经元改变;蛋白质组学与靶向通路分析表明氟哌啶醇诱导的细胞内信号模式与LRRK2激酶活性增高相似。研究提示LRRK2激酶在纹状体多巴胺D2受体信号及氟哌啶醇不良运动副作用中起关键作用。

要点

  • LRRK2激酶抑制可改善氟哌啶醇诱导的小鼠运动改变。
  • LRRK2激酶抑制干扰氟哌啶醇诱导的间接通路纹状体神经元改变。
  • 氟哌啶醇诱导的细胞内信号模式与LRRK2激酶活性增高相似。

核心结论

  • 研究提示LRRK2激酶在纹状体多巴胺D2受体信号中起关键作用,该信号 underlying 氟哌啶醇的不良运动副作用。

研究设计与样本

  • 采用药理学或遗传学抑制LRRK2激酶,以及表达致病突变LRRK2(激酶活性增高)的敲入小鼠模型,系统探索氟哌啶醇与LRRK2的汇聚信号。

主要发现

  • 行为学检测显示LRRK2激酶抑制改善氟哌啶醇诱导的小鼠运动改变。
  • 电生理与解剖学方法结合揭示LRRK2激酶抑制干扰氟哌啶醇诱导的改变,且特异性地作用于间接通路纹状体神经元。
  • 蛋白质组学与靶向细胞内通路分析表明氟哌啶醇诱导的细胞内信号模式与LRRK2激酶活性增高相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Haloperidol is used to manage psychotic symptoms in several neurological disorders through mechanisms that involve antagonism of dopamine D2 receptors that are highly expressed in the striatum. Significant side effects of haloperidol, known as extrapyramidal symptoms, lead to motor deficits similar to those seen in Parkinson's disease and present a major challenge in clinical settings. The underlying molecular mechanisms responsible for these side effects remain poorly understood. Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) has an essential role in striatal physiology and a known link to dopamine D2 receptor signaling. Here, we systematically explore convergent signaling of haloperidol and LRRK2 through pharmacological or genetic inhibition of LRRK2 kinase, as well as knock-in mouse models expressing pathogenic mutant LRRK2 with increased kinase activity. Behavioral assays show that LRRK2 kinase inhibition ameliorates haloperidol-induced motor changes in mice. A combination of electrophysiological and anatomical approaches reveals that LRRK2 kinase inhibition interferes with haloperidol-induced changes, specifically in striatal neurons of the indirect pathway. Proteomic studies and targeted intracellular pathway analyses demonstrate that haloperidol induces a similar pattern of intracellular signaling as increased LRRK2 kinase activity. Our study suggests that LRRK2 kinase plays a key role in striatal dopamine D2 receptor signaling underlying the undesirable motor side effects of haloperidol. This work opens up new therapeutic avenues for dopamine-related disorders, such as psychosis, also furthering our understanding of Parkinson's disease pathophysiology.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chen C, Masotti M, Shepard N, et al. LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons. Mol Psychiatry. 2025. PMID: 40269187. doi:10.1038/s41380-025-03030-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。